Precision Reprogramming iPSCs To Generate a Source of Defined, Scalable Human Cells
See how bit.bio's platform uses opti-ox technology to consistently convert stem cells into defined human cells. The resulting cells enable scalable disease research and drug discovery, with time and cost improvements over traditional technologies.
Interested in seeing more content from bit.bio?
Discover all their latest news, webinars, products and more by clicking the link below.